Cargando…
Transcript-Targeted Therapy Based on RNA Interference and Antisense Oligonucleotides: Current Applications and Novel Molecular Targets
The development of novel target therapies based on the use of RNA interference (RNAi) and antisense oligonucleotides (ASOs) is growing in an exponential way, challenging the chance for the treatment of the genetic diseases and cancer by hitting selectively targeted RNA in a sequence-dependent manner...
Autores principales: | Barresi, Vincenza, Musmeci, Camillo, Rinaldi, Alessandro, Condorelli, Daniele Filippo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408055/ https://www.ncbi.nlm.nih.gov/pubmed/36012138 http://dx.doi.org/10.3390/ijms23168875 |
Ejemplares similares
-
Antisense Oligonucleotides and RNA Interference
por: Kher, Gitanjali, et al.
Publicado: (2011) -
Targeting oncogenic KRAS with molecular brush-conjugated antisense oligonucleotides
por: Wang, Dali, et al.
Publicado: (2022) -
Aberrations of Chromosomes 1 and 16 in Breast Cancer: A Framework for Cooperation of Transcriptionally Dysregulated Genes
por: Privitera, Anna Provvidenza, et al.
Publicado: (2021) -
Improved targeting of miRNA with antisense oligonucleotides
por: Davis, Scott, et al.
Publicado: (2006) -
Targeted Molecular Therapeutics for Parkinson's Disease: A Role for Antisense Oligonucleotides?
por: Li, Dunhui, et al.
Publicado: (2022)